Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma is set to present at the Jefferies London Healthcare Conference to discuss ...
GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...
Fourteen-year-old Sirish Subash won the 3M Young Scientist Challenge with his invention, PestiSCAND. This AI-powered device ...
Investor's Business Daily on MSN2h
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit TherapeuticsMerck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug from China's LaNova Medicines.Please watch the video at Investors.com - ...
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback